Microbial Fermentation Technology Market Report 2026

The microbial fermentation technology market size has grown strongly in recent years. It will grow from $40.76 billion in 2025 to $44.32 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to growth of pharmaceutical and biotech manufacturing, increasing demand for antibiotics and vaccines, expansion of industrial biotechnology applications, availability of fermentation infrastructure, rising research activity in microbiology.

The microbial fermentation technology market size is expected to see strong growth in the next few years. It will grow to $59.63 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing demand for biologics and biosimilars, rising investments in sustainable bio-based production, expansion of precision fermentation applications, growing focus on process automation, increasing adoption of digital bioprocessing tools. Major trends in the forecast period include increasing adoption of high-efficiency bioreactors, rising focus on scalable fermentation processes, growing use of advanced microbial strain engineering, expansion of continuous fermentation techniques, enhanced process monitoring and control.

The increasing demand for alcoholic beverages is expected to drive the growth of the microbial fermentation technology market going forward. Alcoholic beverages are fermented drinks containing ethyl alcohol (ethanol), produced from sugars in fruits, grains, plant saps, honey, tubers, and other natural sources. This rising demand is fueled by changing lifestyles and the growing popularity of healthier alcoholic options, such as low-calorie, low-alcohol, and organic beverages. Microbial fermentation technology is essential in alcohol production, enabling precise control, customization, scalability, and environmentally sustainable fermentation processes. For instance, in February 2023, according to the Distilled Spirits Council of the United States, Inc. (DISCUS), a US-based national trade association, the spirits sector recorded supplier sales of US $37.7 billion, with volumes reaching 308.8 million 9‑litre cases (a 1.2% increase), while maintaining over 42% of the total U.S. beverage alcohol market share. Therefore, the increasing demand for alcoholic beverages is driving the growth of the microbial fermentation technology market.

Major companies operating in the microbial fermentation technology market are focusing on forming advanced strategic partnerships to strengthen research capabilities, broaden fermentation-based product pipelines, and accelerate commercialization of next-generation bio-based materials. Strategic partnerships in microbial fermentation involve collaborations where organizations combine expertise in strain engineering, bioprocess optimization, and scalable manufacturing to enhance production efficiency and bring sustainable fermentation products to market more quickly. For instance, in April 2023, Solvay, a Belgium-based materials and chemicals company, entered a multi-year strategic collaboration with Ginkgo Bioworks, a U.S.-based synthetic biology company, to co-develop sustainable biopolymers through microbial fermentation. The partnership leverages Ginkgo’s strain-design and bioengineering capabilities alongside Solvay’s industrial R&D infrastructure to accelerate innovation, scale-up, and commercialization of renewable, high-value specialty materials.

In June 2024, Lesaffre S.A., a France-based global leader in fermentation and microorganism technologies, acquired DSM-Firmenich’s yeast extract business for an undisclosed amount. Through this acquisition, Lesaffre aims to strengthen its innovation capabilities in yeast-derivative processing and expand its portfolio of savory-ingredient solutions by integrating DSM-Firmenich’s specialized processing technologies and team of 46 experts. DSM-Firmenich N.V. is a Switzerland-based company whose yeast extract unit develops yeast-derived ingredients for savory applications and microbial fermentation processes.

Major companies operating in the microbial fermentation technology market are Cargill Inc., Archer Daniels Midland Company, BASF SE, Evonik Industries AG, Royal DSM NV, Ajinomoto Co Inc., Lonza Group, Novozymes A/S, Ginkgo Bioworks Inc., Amyris Inc., Biovectra Inc., BIOZEEN, MycoTechnology Inc., Unibio A/S, Locus Fermentation Solutions, Lygos Inc., Amano Enzyme Inc., ZymoChem Inc., Conagen Inc., NovoNutrients, F. Hoffmann-La Roche AG, AGC Group, Givaudan SA.

Asia-Pacific was the largest region in the microbial fermentation technology market in 2025. The regions covered in the microbial fermentation technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbial fermentation technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the microbial fermentation technology market by increasing costs of imported bioreactors, sensors, control systems, enzymes, and specialized fermentation equipment. Bio-pharmaceutical and industrial biotechnology producers in North America and Europe are most affected due to reliance on imported high-precision equipment, while Asia-Pacific faces cost pressure on export-oriented fermentation setups. These tariffs elevate capital investment requirements and delay facility expansions. However, they are also driving local manufacturing of fermentation equipment, regional supplier development, and innovation in cost-efficient bioprocess technologies.

The microbial fermentation technology market research report is one of a series of new reports that provides microbial fermentation technology market statistics, including microbial fermentation technology industry global market size, regional shares, competitors with a microbial fermentation technology market share, detailed microbial fermentation technology market segments, market trends and opportunities, and any further data you may need to thrive in the microbial fermentation technology industry. This microbial fermentation technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Microbial fermentation technology involves the use of microorganisms such as bacteria, yeast, or fungi to produce valuable substances through controlled fermentation processes. This technology requires creating optimal conditions for the growth and metabolism of specific microorganisms, including appropriate nutrients, temperature, pH, and oxygen levels.

The primary types of microbial fermentation technology include medical, industrial, alcoholic beverages, food, and feed products. Medical microbial fermentation uses microorganisms such as bacteria, yeast, and fungi to produce medical and pharmaceutical products through fermentation. These products are utilized in various applications, including antibiotics, probiotic supplements, monoclonal antibodies, recombinant proteins, biosimilars, vaccines, enzymes, and small molecules. They are employed by various end users, such as biopharmaceutical companies, contract research organizations (CROs), contract manufacturing organizations (CMOs), contract development and manufacturing organizations (CDMOs), and academic and research institutions.

The microbial fermentation technology market consists of revenues earned by entities by providing services such as analytical and quality control services, research and development (R&D) services, equipment and bioreactor services, and data management and bioinformatics. The market value includes the value of related goods sold by the service provider or included within the service offering. The microbial fermentation technology market also includes sales of pharmaceutical products, biofuels and biochemicals, and specialty chemicals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.